Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock
AMLX(NASDAQ:AMLX) CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the pricing of an underwritten public offering of 17,500,000 shares of its common stock at a public offering price of $10.00 per share. All of the shares of common stock are being offered by Amylyx. In addition, Amylyx has granted the underwriters a 30-day option to purchase up to an additional 2,625,000 shares of its common stock at the public offering price per share, les
Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock
AMLX(NASDAQ:AMLX) CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock
Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)
AMLXCAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
AMLXCAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results
AMLXCAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results
FDA Grants Fast Track Designation To Amylyx Pharma's AMX0114, Investigational Antisense Oligonucleotide Targeting Calpain-2 For ALS Treatment
AMLXMizuho Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $8
AMLXAmylyx Pharmaceuticals Announced Week 48 Data From The Phase 2 Open-label HELIOS Trial Of AMX0035 In Adults Living With Wolfram Syndrome
AMLXHC Wainwright & Co. Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $16
AMLXAmylyx Pharma Q1 EPS $(0.42) Beats $(0.49) Estimate
AMLXExploring Amylyx Pharma's Earnings Expectations
AMLXLumentum Holdings To Rally Around 46%? Here Are 10 Top Analyst Forecasts For Wednesday
AMLXThis Logitech International Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
AMLXLeerink Partners Upgrades Amylyx Pharmaceuticals to Outperform, Raises Price Target to $10
AMLXAmylyx Pharma Announces First Participant Dosed In Pivotal Phase 3 LUCIDITY Clinical Trial Of Avexitide For Treatment Of Post-bariatric Hypoglycemia
AMLXAmylyx Pharmaceuticals Announced That The First Participant Has Been Dosed In LUMINA, Phase 1, Multinational, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Clinical Trial Of AMX0114 In People Living With Amyotrophic Lateral Scleros
AMLXMizuho Upgrades Amylyx Pharmaceuticals to Outperform, Raises Price Target to $7
AMLXAmylyx Pharmaceuticals To Present At 24th Annual Needham Virtual Healthcare Conference
AMLXHello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
AMLXHC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $12 Price Target
AMLXAmylyx Pharma Q4 EPS $(0.55) Misses $(0.52) Estimate
AMLXAmylyx Prices $60M Public Offering Of 17.1M Shares At A Price Of $3.50 Each
AMLXReported Earlier, Amylyx Pharmaceuticals Launches Public Offering Of Common Stock, Aims To Advance Pipeline And Operations
AMLXCrude Oil Rises Sharply; US Homebuilder Sentiment Surges In November
AMLXTwist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday
AMLXThis Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
AMLXBaird Upgrades Amylyx Pharma to Outperform, Raises Price Target to $11
AMLXGoldman Sachs Maintains Neutral on Amylyx Pharma, Raises Price Target to $40
AMLXUS Stocks Flat, Crude Oil Rises 2%
AMLXU.S. stocks traded almost flat in volatile trading on Thursday following the release of jobless claims data.
4 Analysts Have This to Say About Amylyx Pharma
AMLXAnalysts have provided the following ratings for Amylyx Pharma (NASDAQ:AMLX) within the last quarter:
US Stocks Turn Higher, Nasdaq Jumps 100 Points
AMLXU.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday.
After Initial Skepticism FDA's Adcomm Backs Amylyx's Amyotrophic Lateral Sclerosis Hopeful
AMLXCitigroup Maintains Buy on Amylyx Pharma, Raises Price Target to $48
AMLXAmylyx Pharmaceuticals Shares Resume Trading; Shares Up ~85% Premarket
AMLXSVB Leerink Maintains Outperform on Amylyx Pharma, Raises Price Target to $50
AMLX